Comprehensive tech-enabled checkup service Q Bio scores $40M
Summary
Last week tech-enabled health assessment company Q Bio emerged out of stealth mode and announced a $40 million in Series B funding. We also aggregate your entire medical history and do a genetic analysis,” Jeff Kaditz, CEO and cofounder of Q Bio, wrote to MobiHealthNews in an email. The bioinformatics platform behind the Q Dashboard is the first to be able to automatically surface the most relevant clinical chemical and anatomical changes in a person’s body broken down by the major subsystems, weighted by their genetic, medical history and lifestyle risks.” The idea is that the system can learn each individual patient’s norms in order to pinpoint specific risks or previously undetected conditions, instead of comparing the patient to population data. This is a very complicated problem we are trying to solve for and what we currently offer is just a small piece of the overall puzzle.” While the bulk of medical research focuses on so called “sick-care,” there are several companies and studies taking a look at what normal means. The initiative’s aim is to collect data from 10,000 participants over the course of four years in order to gain insights about health and progression into disease.